» Articles » PMID: 23162135

Immunization of Macaques with Soluble HIV Type 1 and Influenza Virus Envelope Glycoproteins Results in a Similarly Rapid Contraction of Peripheral B-cell Responses After Boosting

Overview
Journal J Infect Dis
Date 2012 Nov 20
PMID 23162135
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

The envelope glycoproteins (Env) represent a critical component of a successful antibody-mediated human immunodeficiency virus type 1 (HIV-1) vaccine. However, immunization with soluble Env was reported to induce short-lived antibody responses, suggesting that Env has unusual immunogenic properties. Here, we directly compared the magnitude and durability of B-cell responses induced by HIV-1 Env and an unrelated soluble viral protein, influenza virus hemagglutinin (HA), in simultaneously inoculated macaques. We demonstrate robust peak responses followed by rapid contraction of circulating antibody and memory B cells for both antigens, suggesting that short-lived responses are not unique to HIV-1 Env but may be a common feature of soluble protein vaccines.

Citing Articles

SARS-CoV-2 protein subunit vaccination of mice and rhesus macaques elicits potent and durable neutralizing antibody responses.

Mandolesi M, Sheward D, Hanke L, Ma J, Pushparaj P, Perez Vidakovics L Cell Rep Med. 2021; 2(4):100252.

PMID: 33842900 PMC: 8020888. DOI: 10.1016/j.xcrm.2021.100252.


Persistence of HIV-1 Env-Specific Plasmablast Lineages in Plasma Cells after Vaccination in Humans.

Basu M, Piepenbrink M, Francois C, Roche F, Zheng B, Spencer D Cell Rep Med. 2020; 1(2).

PMID: 32577626 PMC: 7311075. DOI: 10.1016/j.xcrm.2020.100015.


Env Exceptionalism: Why Are HIV-1 Env Glycoproteins Atypical Immunogens?.

Klasse P, Ozorowski G, Sanders R, Moore J Cell Host Microbe. 2020; 27(4):507-518.

PMID: 32272076 PMC: 7187920. DOI: 10.1016/j.chom.2020.03.018.


Vaccine-Induced Protection from Homologous Tier 2 SHIV Challenge in Nonhuman Primates Depends on Serum-Neutralizing Antibody Titers.

Pauthner M, Nkolola J, Havenar-Daughton C, Murrell B, Reiss S, Bastidas R Immunity. 2018; 50(1):241-252.e6.

PMID: 30552025 PMC: 6335502. DOI: 10.1016/j.immuni.2018.11.011.


Induction of Robust B Cell Responses after Influenza mRNA Vaccination Is Accompanied by Circulating Hemagglutinin-Specific ICOS+ PD-1+ CXCR3+ T Follicular Helper Cells.

Lindgren G, Ols S, Liang F, Thompson E, Lin A, Hellgren F Front Immunol. 2017; 8:1539.

PMID: 29181005 PMC: 5693886. DOI: 10.3389/fimmu.2017.01539.